Califf: Rare Disease Hub Will Develop Methods To Guide Approvability Determinations

 
• By Sarah Karlin-Smith
FDA Commissioner Robert Califf
FDA Commissioner Robert Califf discussed the FDA's new rare disease hub during a 27 September Alliance for a Stronger FDA event. (Screenshot from Alliance for Stronger FDA webinar)

More from Rare Diseases

More from Pathways & Standards